Search
for

    Sort by

    Research 61–90 of 160

    1. Estudio clínico-patológico sobre el cáncer de próstata incidental en pacientes intervenidos bajo el supuesto diagnóstico de HBP sintomática Actas Urológicas Españolas · 2006
    2. <i>Retraction of:</i> Bansal and Arora. J Endourol. Epub ahead of print; DOI: 10.1089/end.2016.0696 Journal of endourology · 2017
    3. Diagnosis and treatment of prostatitis after TURP 国际泌尿系统杂志 · 2011
    4. Clinics in diagnostic imaging (221) Singapore Medical Journal · 2024
    5. 1726: Risk Decrease of Intra-Operative Bleeding During TURP with the Uptake of Finasteride: Evaluation of VEGF and CD34 The Journal of Urology · 2007
    6. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    7. Finasteride as a Neo-Adjuvant Treatment for TURPLiterature Review Journal of urology and nephrology open access · 2016
    8. Key Clinical Trials in BPH 2002 · 4 citations
    9. Lower Urinary Tract Symptoms in Men JAMA · 2025
    10. An Unusual Presentation of Massive Asymptomatic Urinary Retention in a 63-Year-Old Male With Iron Deficiency Anaemia Cureus · 2025
    11. Clinical Analysis of Parkinson's Disease with Urinary Bladder Dysfunction:A Report of 64 Cases Chinese Journal of General Practice · 2011
    12. This Month in Clinical Urology The Journal of Urology · 1999
    13. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005 · 3 citations
    14. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. The Journal of Urology · 2005
    15. The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients The Journal of Urology · 2003 · 90 citations
    16. What do we know about phytotherapy of benign prostatic hyperplasia? Life Sciences · 2015 · 67 citations
    17. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors The Journal of Urology · 2018 · 20 citations
    18. Bladder cancer survival in men using 5-alpha-reductase inhibitors European Urology Supplements · 2018 · 3 citations
    19. Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? The Journal of Urology · 2017 · 1 citations
    20. JOURNAL SCAN Medical Journal Armed Forces India · 1997
    21. 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS The Journal of Urology · 2013
    22. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992 · 1040 citations
    23. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician BJU international · 2004 · 98 citations
    24. Association of Suicidality and Depression With 5α-Reductase Inhibitors JAMA Internal Medicine · 2017 · 90 citations
    25. Association of Benign Prostatic Hyperplasia with Male Pattern Baldness Urology · 1998 · 54 citations
    26. Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial British Journal of Cancer · 2009 · 49 citations
    27. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects Case Reports · 2015 · 39 citations
    28. The placebo effect and randomized trials: analysis of conventional medicine Urologic clinics of North America · 2002 · 26 citations
    29. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    30. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations